Results 141 to 150 of about 310,012 (268)
Facial Cosmetic Therapy Use Among Patients With Systemic Sclerosis: An Australian Cohort Study
Arthritis Care &Research, EarlyView.Objective
Systemic sclerosis (SSc) is associated with numerous facial manifestations for which patients may engage in cosmetic therapies. It is unclear how patients with SSc use these therapies. This study sought to characterize patient engagement and experiences with cosmetic therapies for SSc‐related and non‐SSc–related facial changes.Zachary Warren, Diane Apostolopoulos, Gene‐Siew Ngian, Amanda M. Saracino, Laura Ross, Nava Ferdowsi, Jennifer Walker, Cindy Hall, Kim Griggs, Susanna Proudman, Wendy Stevens, Joanne Sahhar +11 morewiley +1 more sourceCorrection: Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub‑analysis of the ProDERM Study. [PDF]
Rheumatol TherAggarwal R, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Clodi E, Levine T, Charles-Schoeman C, ProDERM investigators. +12 moreeuropepmc +1 more sourceClinical Characteristics and Concordance of Anti‐MDA5 Antibodies: A Multicenter Australian Study
Arthritis Care &Research, EarlyView.Objective
In Australia, anti‐MDA5 antibodies are exclusively tested by a line immunoblot assay (LIA). The clinical concordance of an LIA‐positive anti‐MDA5 result is unclear. We aimed to describe the clinical features and determine the clinical concordance of patients with anti‐MDA5 antibodies. Methods
Electronic records of a multisite cohort (patients Syed B. Ali, Thomas Khoo, Keeran Shivakumar, Adam Caroll, Lauren Hender, Dimitra Beroukas, Kim Griggs, Celina Jin, Theo De Malmanche, Jessica Day, Gabor Major, Vidya Limaye +11 morewiley +1 more sourceImpact of Severe COVID-19 on Interstitial Lung Disease in Autoimmune Systemic Diseases. [PDF]
Respirol Case RepFerri C, de Pinto M, Murdaca G, De Luca G, Beigi DMR, Caira V, Foti R, Cito A, Naclerio C, Luppino JME, Spinella A, Orlandi M, Batani V, Lumetti F, Prampolini F, Varcasia G, Foti R, Riccieri V, Iannone F, Antonelli A, Giuggioli D, COVID‐19 and Autoimmune Systemic Diseases Italian Study Group. +21 moreeuropepmc +1 more sourceExtending Service Beyond Active Duty: Generalizability of Rheumatoid Arthritis Research Conducted Among US Veterans
Arthritis Care &Research, EarlyView.Biomedical research involving US veterans continues to advance health care beyond the Veterans Health Administration. This is particularly true in rheumatoid arthritis (RA), where veteran‐centric research has uncovered novel insights into pathogenesis, risk factors, and disease manifestations, informing clinical care and research across both veteran ...Austin M. Wheeler, Joshua F. Baker, Jennifer L. Barton, Maria I. Danila, Tate M. Johnson, Kamini Kuchinad, Kaleb Michaud, Amir A. Razmjou, J. Steuart Richards, Namrata Singh, Isaac D. Smith, Katherine D. Wysham, Grant W. Cannon, Bryant R. England, Amy Joseph, Deana Lazaro, Katherine P. Liao, Courtney Loecker, Andreas Reimold, Beth I. Wallace, Ted R. Mikuls +20 morewiley +1 more sourceRheumatologists' expectations and perceptions of T-cell redirecting therapies: results from a cross-sectional survey. [PDF]
Rheumatol IntMeinecke A, Knitza J, Witte T, Rademacher J, Müller F, Düsing C, Zeeck M, Grieshaber-Bouyer R, Hagen M, Haase I, Holzer MT, Working Group Young Rheumatologists of the German society for Rheumatology and Immunology. +11 moreeuropepmc +1 more sourceValidation of Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric Measures for Children With Chronic Nonbacterial Osteomyelitis
Arthritis Care &Research, EarlyView.Objective
To assess the validity of the Patient‐Reported Outcomes Measurement Information System (PROMIS) Pediatric measures in patients with chronic nonbacterial osteomyelitis (CNO). Methods
Within the longitudinal patient registry of CNO, English‐speaking patients aged 8 years and older self‐reported PROMIS Pediatric measures of fatigue, pain ...Mary M. Eckert, Eveline Y. Wu, Melissa Oliver, Joshua Scheck, Sivia Lapidus, Ummusen Kaya Akca, Shima Yasin, Aleksander Lenert, Sara Stern, Antonella Insalaco, Manuela Pardeo, Gabriele Simonini, Edoardo Marrani, Xing Wang, Bin Huang, Leonard K. Kovalick, Natalie Rosenwasser, Erin Balay‐Destrude, Gabriel Casselman, Adriel Liau, Ava Klein, Yurong Shao, Claire Yang, Molly Briggs, Ethan Mueller, Emily Deng, Paige Rhiannon Trunnell, Iris Hamilton, Elise Machrone, Doaa Mosad Mosa, Lori Tucker, Hermann Girschick, Ronald M. Laxer, Georgina Tiller, Jonathan Akikusa, Christian M. Hedrich, Karen Onel, Fatma Dedeoglu, Marinka Twilt, Seza Ozen, Polly J. Ferguson, Laura Schanberg, Bryce B. Reeve, Yongdong Zhao +43 morewiley +1 more sourceRisk of new primary cancer, locoregional progression or metastasis associated with bDMARDs and tsDMARDs in patients with rheumatoid arthritis and prior cancer: insights from the ARCA registry. [PDF]
RMD OpenMolina-Collada J, Plasencia-Rodriguez C, García-García V, Del Bosque I, Pavía-Pascual M, Villapún Burgoa B, Bourgeois-Avella C, Roig-Kim M, Narváez J, Hernández-Rodríguez I, Saez JC, Almeida C, García-Dorta A, Uriarte Itzazelaia E, Campos D, Dos-Santos R, Pérez-Pampín E, Jiménez Núñez FG, Fernández-Fernández E, Villalba A, Bou N, Pérez-García C, Rusinovich Lovgach O, Martínez Rodado A, González R, Cepas-Gutiérrez FJ, Olivas-Vergara O, Berrocal M, Molina N, González Mazón I, Toledano E, Tortosa-Cabañas M, Vellosillo González P, González Navarro P, Navarro-Compán V, Carmona L, ARCA project collaborative group. +36 moreeuropepmc +1 more source
